At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are, allowing you to thrive both personally and professionally. This is how we aim to prevent, stop and cure diseases and ensure everyone has access to healthcare today and for generations to come. Join Roche, where every voice matters.
The Patient Access Partner is a strategic role responsible for driving and executing the integrated access, pricing, and policy strategy for an assigned Disease Area (DA) Ecosystem. This role translates national policy into tangible access and pricing decisions at the disease level, focusing on improving and accelerating access to innovation. As a key player in the integrated access strategy, the Partner identifies shared purpose and value, co-creates flexible pricing solutions with DA Squads, and implements them across the ecosystem to ensure better health outcomes for more patients faster.
1. Ecosystem & Disease Area Policy Strategy
Strategic Alignment Execute and develop Disease Area Policy activities that support the strategic outcomes of the Squad. This involves ensuring all access strategies are aligned with current and anticipated national legislative trends.
Integrated Planning Manage the end-to-end patient access process for assigned therapeutic areas, coordinating strategy from monitoring early-stage portfolios to achieving final reimbursement.
System Shaping Catalyze the ability to see broader trends in healthcare systems, bringing external insights into Roche to influence DA strategy and sharing Roche’s expertise with the external ecosystem.
Pricing Strategy: Responsible for defining the Pricing Strategy (e.g., target price, discount caps, and risk-share structures) based on commercial ambition
2. Pricing, Negotiation, and Technical Execution
Reimbursement Journey: Acts as the Strategic Project Lead for the reimbursement journey, responsible for the overall timeline, squad alignment, and final negotiation outcome.
Strategic Negotiation Serves as the Primary Point of Contact (PPOC) for strategic therapy area payer dialogue, pricing negotiations, and policy-level external meetings.
Value Proposition: Accountable for translating the technical value proposition into a commercial narrative and negotiation strategy tailored to the specific payer or Disease Area Squad needs.
External Relationship Management Maintain and foster a relevant network with pricing and reimbursement decision-makers within the healthcare system to support favorable commercial conditions.
3. Cross-Functional Squad Partnership
Core Squad Member Act as a primary member of Disease Area Squads, connecting Market Access strategy, Policy, and Pricing directly to commercialization excellence and field execution.
Evidence Generation Responsible for identifying strategic evidence gaps required to support negotiation and commercial goals (e.g., 'We need to prove X to the payer').
Enterprise Partnership: Work as a strategic bridge between high-level market access strategy and operational reality, partnering with Finance and Brand teams to recommend and shape national access strategies.
Collaboration Partner cross-functionally with Healthcare System Partners and Patient Journey Partners to leverage internal networks and pull in resources needed for the therapeutic area.
Strategic Agility Ability to maintain focus on long-term strategy while successfully adapting to changing environmental and legislative conditions.
System Thinking Capability to think from an enterprise level to bring the best possible outcomes to the local health environment and the broader Roche global network.
Impactful Communication Skilled in articulating complex value propositions and consulting with diverse external and internal stakeholders.
Agile Mindset Desire and ability to work in an agile, self-managed way based on trust and continuous learning.
VACC Leadership Acts as a Visionary, Architect, Catalyst, and Coach to remove healthcare bottlenecks and empower teams.
Education University degree (Master’s degree ) in Business, Economy, Health Economics, Medicine, Pharmacy, Life Sciences.
Experience
Minimum 5 years in Market/Patient Access or Health Policy area (Hands-on experience in the Patient Access field with a good understanding of healthcare financing, reimbursement systems, and relevant compliance regulations) and
Minimum 7 years of experience in the area of Health Care in Slovakia
Digital Literacy Ability to leverage digital means and tools for the benefit of all stakeholders.
Salary starts from 3699 EUR gross/month, final salary will depend on the level of skills and experience.
A healthier future drives us to innovate. Together, more than 100’000 employees across the globe are dedicated to advance science, ensuring everyone has access to healthcare today and for generations to come. Our efforts result in more than 26 million people treated with our medicines and over 30 billion tests conducted using our Diagnostics products. We empower each other to explore new possibilities, foster creativity, and keep our ambitions high, so we can deliver life-changing healthcare solutions that make a global impact.
Let’s build a healthier future, together.
Roche is an Equal Opportunity Employer.

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).
For more information, please visit https://careers.roche.com
Read our community guidelines here:
https://www.roche.com/some-guidelines.htm
#Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation